Skip to main content

IM Cannabis Corp.

corporate_fare Company Profile

IM Cannabis Corp.

IMCC·NASDAQ·Life Sciences·CIK 0001792030

We are an international cannabis company focused on the importation, distribution, and sale of medical cannabis products to medical patients in Israel and Germany. Following regulatory reforms in Germany on April 1, 2024, we shifted our focus and resources to the German cannabis market. We utilize a cross-border supply chain and distribution infrastructure. In Israel, we import, distribute, and sell cannabis to local medical patients through medical cannabis retail pharmacies, online platforms, a distribution center, and logistical hubs operated by IMC Holdings' subsidiaries, adhering to Israeli regulatory requirements. We also maintain proprietary genetics through third-party cultivation facilities in Israel and continue to offer medical cannabis products under our brands through strategic alliances with suppliers. Throughout 2024 and 2025, we implemented strategic measures in Israel to enhance operational efficiency, reduce costs, and improve business performance, including optimizing logistics and distribution, streamlining workforce and facilities, and adapting to geopolitical challenges. Key actions in 2024 and 2025 included engaging a new third-party processing facility, changing shipping and distribution service providers, reducing headcount, closing certain trading activities, and adjusting operations due to logistical disruptions from regional hostilities. We operate in the retail segment in Israel through IMC Holdings, holding two licensed pharmacies: Vironna, serving the Arab consumer segment, and Pharm Yarok, a large pharmacy in the Sharon plain area with a call center for deliveries. We also operate home-delivery services and an online retail platform under "Pharm Yarok," which includes a customer service center. On April 9, 2024, Pharm Yarok entered into a strategic distribution agreement with Vessel Brand Inc.

IM Cannabis Corp. (NASDAQ:IMCC) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 35 items for IMCC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-20, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 8/10, with 11 rated 8 or above. Recent SEC coverage for IMCC spans 6-K, F-3, 424B5.

Recent high-impact activity:

  • Founder Ousted as CEO; IM Cannabis Names Zalayet to Lead Tech Pivot
  • IM Cannabis Sets 3:1 Reverse Split for Nov 23 to Chase $1 Nasdaq Floor
  • IM Cannabis Q3 Revenue Falls 68% to C$1.65M; Going-Concern Warning Reiterated
  • IM Cannabis Registers 25.3M Resale Shares — ~1,375% of Its 1.84M Outstanding
  • IM Cannabis Raises US$1.2M Convertible Note With 3.94M Warrants and a Quarterly Standby Facility

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
CA$54.73M CAD
Net Income
-CA$11.75M CAD
Op. Cash Flow
CA$4.72M CAD
Free Cash Flow
CA$4.7M CAD
Gross Profit
CA$9.69M CAD
Operating Income
-CA$11.59M CAD
Cash & Equivalents
CA$2.73M CAD
Total Debt
CA$1.87M CAD
Debt / Equity
-0.52×
Net Margin
-21.5%
Shares Outstanding
5.89M sh
Source: 20-F · filed 2026-03-30 · accession 0001178913-26-001877

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 14,580 shares in IMCC as of the October 30, 2026 settlement, a 59.6% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 53.3% of IMCC volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)14,580 shares as of October 30, 2026
Change vs prior period▼ 59.6%
Days to cover1.00 at avg daily volume of 73,536
Daily short volume (FINRA facilities)53.3% of 1,015,575 shares on November 20, 2026
5-day average short volume51.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

High risk

Filing-implied dilution signals for IMCC, detected from its recent SEC filings · based on capital-structure filings through 2026-11-10.

1 recent capital raise3 shelf registrations

Registered Direct Offering Priced · 66% Share Count Increase

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Insider Transactions

IMCC files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with I →
$0.5215 +4.32% today
52-week range · as of 2026-11-13 $0.50 – $62.4
Market cap
$921.9K
Volume
2.6M (16.0× avg)
3-mo avg 162K
Live data · 2026-11-22 03:02 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed IMCC - Latest Insights

IMCC
Nov 20, 2026, 9:19 AM EST
Source: PR Newswire
Importance Score:
7
Updated Nov 20, 9:26 AM ET — Shakked Shuster became CEO of subsidiary Focus Medical Herbs, succeeding Oren Shuster; Ohad Melnik's board appointment is subject to Israel…
Price at Filing: $0.499
Real-time Price: $0.5215 info
Change: Reverse Stock Split info
Market Cap: $921.897K info
IMCC
Nov 18, 2026, 4:01 PM EST
Source: PR Newswire
Importance Score:
8
Updated Nov 18, 4:12 PM ET — Post-consolidation CUSIP changes to 44969Q604 and ISIN to CA44969Q6040; no fractional shares issued, with fractions of one-half or more rou…
Price at Filing: $0.5356
Real-time Price: $0.5215 info
Change: Reverse Stock Split info
Market Cap: $921.897K info
IMCC
Nov 13, 2026, 5:20 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.580
Real-time Price: $0.5215 info
Change: Reverse Stock Split info
Market Cap: $921.897K info
IMCC
Nov 10, 2026, 4:16 PM EST
Filing Type: F-3
Importance Score:
8
Price at Filing: $0.590
Real-time Price: $0.5215 info
Change: Reverse Stock Split info
Market Cap: $921.897K info
IMCC
Nov 04, 2026, 4:13 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.716
Real-time Price: $0.5215 info
Change: Reverse Stock Split info
Market Cap: $921.897K info
IMCC
Nov 04, 2026, 4:01 PM EST
Source: PR Newswire
Importance Score:
7
Price at Filing: $0.7168
Real-time Price: $0.5215 info
Change: Reverse Stock Split info
Market Cap: $921.897K info
IMCC
Oct 08, 2026, 4:06 PM EDT
Filing Type: F-3
Importance Score:
8
Price at Filing: $1.72
Real-time Price: $0.5215 info
Change: Reverse Stock Split info
Market Cap: $921.897K info
IMCC
Oct 02, 2026, 5:25 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $2.00
Real-time Price: $0.5215 info
Change: Reverse Stock Split info
Market Cap: $921.897K info
IMCC
Sep 25, 2026, 4:15 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $2.88
Real-time Price: $0.5215 info
Change: Reverse Stock Split info
Market Cap: $921.897K info
IMCC
Sep 24, 2026, 4:01 PM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $3.15
Real-time Price: $0.5215 info
Change: Reverse Stock Split info
Market Cap: $921.897K info
IMCC
Sep 24, 2026, 8:15 AM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $2.96
Real-time Price: $0.5215 info
Change: Reverse Stock Split info
Market Cap: $921.897K info
IMCC
Sep 24, 2026, 7:01 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $2.90
Real-time Price: $0.5215 info
Change: Reverse Stock Split info
Market Cap: $921.897K info
IMCC
Sep 23, 2026, 8:37 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $7.74
Real-time Price: $0.5215 info
Change: Reverse Stock Split info
Market Cap: $921.897K info
IMCC
Sep 23, 2026, 7:41 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $10.10
Real-time Price: $0.5215 info
Change: Reverse Stock Split info
Market Cap: $921.897K info
IMCC
Sep 23, 2026, 7:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $4.00
Real-time Price: $0.5215 info
Change: Reverse Stock Split info
Market Cap: $921.897K info
IMCC
Sep 02, 2026, 4:30 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $2.94
Real-time Price: $0.5215 info
Change: Reverse Stock Split info
Market Cap: $921.897K info
IMCC
Aug 18, 2026, 5:01 PM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $0.1019
Real-time Price: $0.5215 info
Change: Reverse Stock Split info
Market Cap: $921.897K info
IMCC
Aug 17, 2026, 8:55 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.0912
Real-time Price: $0.5215 info
Change: Reverse Stock Split info
Market Cap: $921.897K info
IMCC
Aug 17, 2026, 6:32 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $0.1238
Real-time Price: $0.5215 info
Change: Reverse Stock Split info
Market Cap: $921.897K info
IMCC
Aug 13, 2026, 5:08 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.1289
Real-time Price: $0.5215 info
Change: Reverse Stock Split info
Market Cap: $921.897K info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets